William Heiden is a seasoned healthcare executive and board member with over 15 years of experience as a CEO in both public and private biotech companies. Heiden has successfully led organizations in the U.S. and internationally, contributing to the development and commercialization of various pharmaceutical products and overseeing transactions exceeding one billion dollars in acquisitions and licensing. Currently, Heiden serves as Chairman of the Board at MacroGenics, CoreA Therapeutics, and Third Pole Therapeutics, in addition to being a member of the Board of Directors at Atara Biotherapeutics and a board trustee at Boston Collegiate Charter School. Heiden's background includes holding senior leadership roles at notable companies such as AMAG Pharmaceuticals, Schering-Plough Pharmaceuticals/Merck, and Elixir Pharmaceuticals. Academic qualifications include a BS in Finance from the University of Florida, an MBA from Cornell Johnson Graduate School of Management, and a Master's in International Management from Université Catholique de Louvain.
This person is not in the org chart
This person is not in any teams
This person is not in any offices